Ken Griffin acquired 600k Gilead Sciences shares worth $74.3M. That's 0.05% of their equity portfolio (456th largest holding). The first Gilead Sciences trade was made in Q2 2013. Since then Ken Griffin bought shares 62 more times and sold shares on 64 occasions. The stake costed the investor $45.3M, netting the investor a gain of 64% so far.